Light Mode
$22.07 ↑ +0.00 (+0.00%) Trading Up from the previous close of $22.07, $0.36 below the day’s high of $22.43
+0.53 (+2.46%) / 6M
Momentum, market sentiment, and recent alerts
ZLAB reads not so good: price sits above one of the two key moving averages, the 12-month move is -15.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.